iTeos Therapeutics: My Calculations Suggest Q3 Earnings Will Exceed $10 Per Share
naphtalina/iStock via Getty Images
iTeos Therapeutics (NASDAQ:ITOS) received a $625 million upfront payment in a deal with GlaxoSmithKline on August 6, 2021:
“…we received $625 million upfront payment, we will be eligible to receive up to additional $1.45…
